amoksycylina global vet health 500 mg/g proszek do podania w wodzie do picia
global vet health s.l. - amoxicillinum trihydricum - proszek do podania w wodzie do picia - 500 mg/g - indyk; kaczka; kura; świnia
piretamol 300 mg/ml roztwór do podania w wodzie do picia
global vet health s.l. - paracetamolum - roztwór do podania w wodzie do picia - 300 mg/ml - Świnia ( świnia w okresie wzrostu do 40 kg masy ciała)
quinoflox 100 mg/ml roztwór do wstrzykiwań
global vet health s.l. - enrofloxacinum - roztwór do wstrzykiwań - 100 mg/ml - bydło; świnia
pneumospectin 50 mg/ml + 100 mg/ml roztwór do wstrzykiwań
global vet health s.l. - lincomycini hydrochloridum + spectinomycini sulfas tetrahydricus - roztwór do wstrzykiwań - 50 mg/ml + 100 mg/ml - bydło (cielę); indyk; kot; koza; kura; owca; pies; świnia
floxacin 100 mg/ml koncentrat do sporządzania roztworu doustnego
global vet health s.l. - enrofloxacinum - koncentrat do sporządzania roztworu doustnego - 100 mg/ml - indyk; kura
quinoflox 100 mg/ml roztwór do podawania w wodzie do picia
global vet health s.l. - enrofloxacinum - roztwór do podawania w wodzie do picia - 100 mg/ml - królik; kura
imatinib actavis
actavis group ptc ehf - imatinib - leukemia, myelogenous, chronic, bcr-abl positive; precursor cell lymphoblastic leukemia-lymphoma; myelodysplastic-myeloproliferative diseases; hypereosinophilic syndrome; dermatofibrosarcoma - protein kinase inhibitors, antineoplastic agents - imatinib actavis is indicated for the treatment of: , paediatric patients with newly diagnosed philadelphia chromosome (bcr-abl) positive (ph+) chronic myeloid leukaemia (cml) for whom bone marrow transplantation is not considered as the first line of treatment;, paediatric patients with ph+ cml in chronic phase after failure of interferon-alpha therapy, or in accelerated phase or blast crisis;, adult patients with ph+ cml in blast crisis;, adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukaemia (ph+ all) integrated with chemotherapy;, adult patients with relapsed or refractory ph+ all as monotherapy;, adult patients with myelodysplastic/myeloproliferative diseases (mds/mpd) associated with platelet-derived growth factor receptor (pdgfr) gene re-arrangements;, adult patients with advanced hypereosinophilic syndrome (hes) and/or chronic eosinophilic leukaemia (cel) with fip1l1-pdgfr rearrangement;, the treatment of adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. efekt imatinib na wynik przeszczepienia szpiku kostnego nie jest określona. imatinib actavis is indicated for: , in adult and paediatric patients, the effectiveness of imatinib is based on overall haematological and cytogenetic response rates and progression-free survival in cml, on haematological and cytogenetic response rates in ph+ all, mds/mpd, on haematological response rates in hes/cel and on objective response rates in adult patients with unresectable and/or metastatic dfsp. doświadczenie z imatinibom u pacjentów z mds/jest msy, związanych z pdgfr genów permutacji-bardzo ograniczony. brak kontrolowanych badań wykazują kliniczną korzyść lub zwiększone tempo dla tych chorób.
okitask 25 mg granulat powlekany
dompe farmaceutici s.p.a. - ketoprofenum lysinum - granulat powlekany - 25 mg
okitask 25 mg tabletki powlekane
dompe farmaceutici s.p.a. - ketoprofenum lysinum - tabletki powlekane - 25 mg
ketoprofen dompé 50 mg granulat do sporządzania roztworu doustnego, w saszetce
dompe farmaceutici s.p.a. - ketoprofenum - granulat do sporządzania roztworu doustnego, w saszetce - 50 mg